Kategorie: joimax® News

joimax® and Red One Medical Partner to Support Expert Endoscopic Minimally Invasive Spine Surgery for Veterans and Active Military

Veröffentlicht am von christine.stump@joimax.com

SAVANNAH, GA – joimax®, a leading developer and marketer of complete systems for endoscopic minimally invasive spinal surgery, and Red One Medical, a Service-Disabled Veteran-Owned Small Business, announced their partnership today. The partnership enables both companies to continue their missions to improve patient care and surgical outcomes with leading edge medical technology and devices.

Red One Medical Founder and CEO Charles Pollak shared, “I am excited to join forces with joimax® to offer their innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery to VA and DoD facilities across the nation, further supporting the government’s goal to improve outcomes and improve efficiency in these facilities.”

Matt Cronin, senior VP of sales and marketing for joimax®, is a U.S. Navy veteran and hailed this partnership: “This is a pivotal moment for joimax® and our long history. We are honored to be a part of improving health care for our many veterans and our brave U.S. military personnel, as well as for their dependents. Our working together with Red One Medical will make endoscopic spine surgery more accessible to this patient population, where a quicker return to both duty and a more active life, is so important.”

About Red One Medical:

Red One Medical is a CVE-certified Service-Disabled Veteran-Owned Small Business (SDVOSB) located in Savannah, GA. Wholly owned and operated by a combat veteran, Red One Medical is a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and Department of Defense (DoD) hospitals. Red One Medical donates a portion of profits to leading charities as part of its mission to support veterans, military families and their communities. To learn more, visit http://www.redonemedical.com/

RED-ONE-joimax-collaboration, Military, veterans, endoscopic spine experts, endoscopic devices, endoscopic systems, treatment

joimax® starts the official sale of its EndoLIF® Delta and DoubleWedge cages. All three members of EndoLIF® family CE approved.

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, GER– July 15, 2019 –joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the official sales launch of its complete EndoLIF® family. EndoLIF® is an instrument set for endoscopic-assisted minimally invasive lumbar interbody fusion. As already announced and showcased at earlier events, the EndoLIF® product line consists of three members now: the well-known EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the latest EndoLIF® Double Wedge Cage. The complete EndoLIF® product family is now CE-approved and fully available. Moreover, the EndoLIF® O/On-Cage is FDA-approved.

All EndoLIF® Implants are manufactured using a 3D printing process, which ensures an open diamond cell structure. The cages are safely implanted via the guide wire and are fillable with bone or bone substitute material. With their rough and porous surface, the implants guarantee optimal bone ingrowth, stability and finally fusion.

The EndoLIF® Cage family provides the right implant for every patient and is the perfect solution for endoscopic spinal fusion. With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact leaving important biomechanical structures in place after surgery.

Like with any endoscopic procedure compared to open surgery, all advantages for fusion are now given with the EndoLIF® program also. With one EndoLIF® Instrument Set all three cages of the EndoLIF® family can be implemented.

Dr. Florian Zentz, (Munich, GER) emphasizes “the extraordinarily high primary stability of the EndoLIF® DoubleWedge-Cage”. He continues enthusiastically: “After insertion the cage sits very firmly in the intervertebral disc space and adjusts the angulation up to 18 degrees, almost directly enabling an optimal lordosis correction.”

Dr. Ralf Wagner, (Frankfurt, GER) is also convinced of the obvious advantages: “The Delta Cage is ideal for the posterior lumbar interbody fusion (PLIF) offering a gentle posterior alternative, especially at level L5-S1 with its large interlaminar window.

joimax® Showcases New Electromagnetic Navigation System Intracs® em at Global Spine Congress (GSC), Toronto and at German Society of Neurosurgery (DGNC), Wurzburg Clinical Trials Start in Europe and Asia

Veröffentlicht am von christine.stump@joimax.com

IRVINE, CA – May 13, 2019 – joimax®,, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is showcasing its Integrated Navigation Tracking & Control System, Intracs®em, at this year’s Global Spine Congress (GSC), which is currently being held in Toronto, Canada. The company is also promoting the system at the annual meeting of the German Society of Neurosurgery (DGNC), being held concurrently in Wurzburg, Germany.

The Intracs®em electromagnetic navigation system is simple to set up, very user-friendly, and seamlessly integrates into the joimax® endoscopic tower. It allows for navigation during any endoscopic procedure performed with the joimax® endoscopic surgical systems, TESSYS® (transforaminal) and iLESSYS® (interlaminar). Beyond that, it can serve as a stand-alone device.

The system relies on electromagnetic tracking, affording simultaneous navigation of multiple instruments such as needles, guiding rods, reamers and endoscopes. It was developed by joimax®  for easy planning of endoscopic approaches to the spine, as well as other minimally invasive procedures, like percutaneous fusions.

Various Intracs®em sensors guarantee the highest accuracy. Plus, for the patients’ benefit, the procedure can be carried out without further X-ray control – only starting X-rays are required. As a result, access, intervention time, and radiation exposure, are reduced to a minimum.

The system is CE-Marked. Currently, clinical trials and applications are running in Europe and Asia, where the product has already launched. In specific Asian countries, like Taiwan, the first systems have been sold and shipped.

Users are very impressed with the usability of the system. “I didn’t expect that navigation for both transforaminal and interlaminar procedures can be made so easy and that the set-up time can be so much streamlined,“ states Prof. Michael Kraus, spine specialist in Augsburg, Germany.  “And for the thoracic approach, it is so precise and a tremendous help,” continues Dr. Erik Traupe, spine specialist in Munich, Germany.

The launch of Intracs®em is a key milestone for joimax®. As part of its global strategy, joimax®  is providing surgeons, worldwide, with the devices they need for safe, easy and gentle spinal therapies, with US-FDA submission planned for Q2, 2019. “We are committed to overcoming any obstacles and concerns related to minimally invasive, endoscopic spine surgery,” states joimax® CEO and Founder Wolfgang Ries. “Our success lies with our innovative, user-friendly devices and instruments, and our ability to provide both doctor and patient with outstanding safety built into our systems.” Moreover, a well established and targeted clinical training program for the spinal surgical community, named CM3, rounds out the joimax® educational offering. Earlier this year, joimax® launched ESPINEA®, an Endoscopic Spine Academy focused on a complete endoscopic spine curriculum. Designed as a full training program to elevate surgeons to the next level of expertise, ESPINEA® offers professional and high-quality education for endoscopic spine treatment specialists, worldwide. The ESPINEA® Training and Education Centers are located in Karlsruhe, Germany in the newly opened joimax® building, and in Irvine, CA, where joimax® opened new labs and training rooms last November.

joimax® presents product portfolio at JSSR in Yokohama Japan
Further continues International Growth Strategy

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, GER– April 18, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is presenting its complete product portfolio at the 48th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR). The annual meeting is currently underway running April 18-20, 2019 in Yokohama, Japan.

Earlier this year, joimax® announced its partnership with United Biomech Japan, Inc., who is overseeing distribution of the complete joimax® product line throughout Japan. Approval of the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is expected within the next couple of months.

“The Japanese market is characterized by a strong demand for innovative products on endoscopic spinal surgery,” explained United Biomech Japan, Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming. There are approximately one thousand Japanese surgeons that are now already interested in doing endoscopic spinal surgery.”

“The patients’ demand for gentle surgery methods that result in a very quick recovery, is continuously increasing,” said joimax® Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese market is another milestone in expanding our global presence to offer superior medical products. Coupled with an outstanding, international training and education program, we’ve positioned ourselves for long-term growth.”

joimax(R) presence at JSSR Yokohama, Japan, endoscopicspine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, Japan, United Biomech Inc., JSSR
joimax(R) presence at JSSR Yokohama, Japan, endoscopicspine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, Japan, United Biomech Inc., JSSR
joimax(R) presence at JSSR Yokohama, Japan, endoscopicspine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, Japan, United Biomech Inc., JSSR

joimax® Hosts International Training Summit to Showcase Innovative Technologies Presents Kambin Award; Introduces Endoscopic Spine Academy

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, GER– March 12, 2019 – Earlier this month, at the international training summit dubbed, Faculty and User Meeting, joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, presented its newest products and technologies. During the two-day event, joimax® also honored four surgeons with the Kambin Award and introduced the Endoscopic Spine Academy, ESPINEA.

The summit took place at the Paracelsus Medical University (PMU) in Salzburg, Austria, March 1-2, 2019 where more than 100 participants attended top-class presentations as well as well a human cadaver lab. The lab was equipped with ten hands-on training stations: six cadaveric stations with 4K image resolution equipment and within those stations, two Intracs® navigation systems where integrated; two stations with Real Spine simulation models; and two stations with the latest EndoTrainer® Plus virtual simulator, which can be used in any lab for training.

The Intracs® em electromagnetic navigation system for endoscopic minimally invasive spine surgery in lumbar and thoracic applications is very easy to set up, extremely user-friendly, and ready to serve as a stand-alone device. Specifically designed for simple and safe access to any spinal target, the system relies on electromagnetic tracking and allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes, also developed by joimax®.

Dr. Erik Traupe (Germering, GER) stated: “I am really surprised how precise and easy navigation can be.”

After multiple successful introductions in 2018, Intracs® em is available globally, except in the United States, where FDA submission is planned in spring 2019.

Another trendsetting innovation presented at the summit: the joimax® TESSYS® Thx, a derivative of the well-known TESSYS®. Designed for a comfortable and safe treatment of decompressions in the thoracic region, it combines a special endoscope for thoracic applications, a viewing angle with 45° adapted to a steeper access route, a reduced diameter and a big working channel.

Jun Seok Bae, MD of the Wooridul Spine Hospital Group in South Korea is very excited about the advantages: “… just great, I want it a.s.a.p. and am ready in my hospital for daily usage!”

Moreover, joimax® showcased its EndoLIF® product line: the well-known 3D-printed EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the latest EndoLIF® Double Wedge Cage, where approval is expected shortly.

Both Dr. Ralf Wagner (Frankfurt, GER) and Dr. Paul Houle (Cape Cod, MA, USA) are convinced of this solution for spinal fusion: “With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact and infection risk is reduced. Using

3D-printing technology, an open diamond cell structure, and a rough and porous surface, the implant ensures optimal bone ingrowth, stability and finally fusion.”

During the summit, the Parviz Kambin-Award was presented under the patronage of the PMU, ESPINEA and joimax® in recognition and honor of outstanding scientific and educational dedication to transforaminal surgery to Christoph P. Hofstetter (Seattle, WA, USA), Jian Shen (Amsterdam, NY, USA), Albert Telfeian (Providence, RI, USA) and Dinh Ngoc Son (Hanoi, Vietnam).

“I am thrilled about the Kambin Award, the most prestigious award in endoscopic spine surgery,” said Jian Shen.

Additionally, joimax® announced the recently founded and globally acting Endoscopic Spine Academy (ESPINEA). Backed by a scientific advisory board, ESPINEA offers professional and high-quality educational programs, specialty workshops and courses, and an opportunity to share knowledge and experiences. The goal of the academy is to elevate surgeons to the next level of expertise in endoscopic spinal treatment modalities.

The first two ESPINEA Board Members are Dr. Menno Iprenburg, NL, longstanding endoscopic surgeon and twice Kambin Award recipient, and Kambin Award recipient Prof. Alastair Gibson, UK, whose been performing endoscopic spine surgery since 2005, using almost all system applications.

joimax® Rolls Out Its Endoscopic Generation 4 Devices and Showcases New 3D-Printed Titanium Implants at the German Spine Society (DWG) Convention

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) / Irvine, CA – December 6, 2018 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is well positioned for Germany’s principal spine convention, German Spine Society (DWG), taking place December 6 to 8 in Wiesbaden, Germany.

Joimax, Endoscopic spine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, EndoLIF Implants, Navigation, Generation4, next Generation, tower, endoscopic

This year, joimax® is focusing on their Endoscopic Tower Generation 4 Devices, an expert solution for spinal surgery. They will showcase the new Camsource® LED, a fully integrated camera and light source system that delivers brilliant images up to 4K; and the Vitegra®, the integrated visualization, documentation and commanding device. This marks the global launch of both devices, including in Europe, Asia, and the United States.

Moreover, joimax® will exhibit its EndoLIF® product line: the well-known 3D-printed EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the EndoLIF® Double Wedge Cage (approval expected shortly).

“The main advantage of the EndoLIF® Implants is the gentle and atraumatic access via gradual tissue dilatation — muscles remain intact and infection risk is reduced. Using 3D-printing technology, an open diamond cell structure, and a rough and porous surface, leads to optimal bone ingrowth, stability and finally fusion,” states Wolfgang Ries, Founder and CEO of the joimax® Group. “Even awake, fusion with very fast patient recovery has started to be realized on the base of endoscopic minimally-invasive techniques.”

Additionally, joimax®  will show Intracs® em, the first complete electromagnetic navigation system for endoscopic minimally invasive spine surgery. Intracs® is an easy to set up, user-friendly system that can serve as a stand-alone device. It relies on electromagnetic tracking and was designed specifically for simple and safe access to any spinal target. It’s the only device on the market that allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes, also developed by joimax®.

Besides an expanded booth presence with daily Meet-the-Expert Sessions, joimax® will again host two lunch symposiums on endoscopic spinal procedures: one covering endoscopic pain therapy, and the other addressing diverse intracanal surgical treatment modalities, including endoscopic fusion.

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.

During the AANS, joimax®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax® procedures.

joimax® is active in 45 countries by now and meanwhile enjoys a strong reputation in Europe and also in Asia which will now spread out into the US-market as well. “The entry in force of the CPT 2017 reimbursement Codebook (Current Procedural Terminology) as of January 1st, 2017, is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques. The codebook now contains the first endoscopic spinal surgery code, under which the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures marketed by joimax® are now eligible in the USA and this will further contribute to fully increase sales in the US as well” states Wolfgang Ries, Founder and CEO of joimax®.

joimax® technologies are based on worldwide intellectual property and the company holds now more than 150 patents and trademarks. Only in 2016 18 patents and patent publications were issued to joimax®. The latest one is Patent No. EP 2 983 622 for the EndoLIF® Cage, which has been introduced to offer a minimally invasive as well as open (TLIF) alternative for fusion in the lumbar spine as an optimal treatment option for surgeons.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs®, the new Interaoperative Navigation Tracking & Control System with which joimax® instruments can be navigated directly at the tip. The Intracs® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® (Lumbar Interbody Fusion) and Percusys® (Percutaneous Screw-Rod Stabilization).

COA 2016 in Beijing, China: joimax® shows major presence and inaugurates new NASS-joimax® MISS training centre

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA and Karlsruhe, Germany – November 28th, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic Association (COA), which has taken place from Nov 17th to 20th, 2016 at China National Convention Center in Beijing, China. During the exhibition, the new NASS – joimax® MISS Training Centre has been inaugurated.

img_6512

The 18th Chinese Orthopedic Association Annual Meeting and the 11th International Congress of Chinese Orthopedic Association (COA) this year has again taken place in Beijing and was visited by around 35,000 surgeons gathering for the latest research results and up to date information on technology and clinical progression in orthopedics including Spine Surgery. joimax® had a major presence with a large booth showing its endoscopic minimally invasive product range. Furthermore on the two major meeting days 30 lectures of well-known experts were given at its booth.

From left to right: Edward Dohring, MD, NASS Board of Directors; Prof. Yue Zhou, Xinqiao Hospital, Chairman of Chinese Society for MISS and joimax® faculty; Jeffrey C. Wang, MD, NASS Board of Directors; Prof. Xiaoguang Liu, Vice President Peking University Third Hospital; Prof. Jie Qiao, President Peking University Third Hospital; Wolfgang Ries, CEO & founder joimax® GmbH; Brad Repsold, NASS Assoc. Executive Director; Michael Roberz, International Sales Director joimax® GmbH; Qinguang You, General Manager joimax® China.
From left to right: Edward Dohring, MD, NASS Board of Directors; Prof. Yue Zhou, Xinqiao Hospital, Chairman of Chinese Society for MISS and joimax® faculty; Jeffrey C. Wang, MD, NASS Board of Directors; Prof. Xiaoguang Liu, Vice President Peking University Third Hospital; Prof. Jie Qiao, President Peking University Third Hospital; Wolfgang Ries, CEO & founder joimax® GmbH; Brad Repsold, NASS Assoc. Executive Director; Michael Roberz, International Sales Director joimax® GmbH; Qinguang You, General Manager joimax® China.

During the COA the new NASS-joimax® MISS Training Centre in China has been inaugurated on Friday Nov. 18th, 2016. The ceremony has taken place at the joimax® booth together with leaders from the Peking University Third Hospital and members of the NASS Board of Directors. The Chinese market is a very important one for joimax®: Chinese surgeons are highly interested in adopting and deepening their knowledge in endoscopic minimally invasive techniques. joimax® is playing a major role in advanced training and is a driving power in the field of continuing education.

“With the launch of TESSYS® IseeUTM, which has been newly designed especially for the Chinese market, joimax® offers an even more simplified access under facilitated orientation”, says Wolfgang Ries, CEO and founder of joimax®. “The existing TESSYS® trays can furthermore be upgraded with the TESSYS® ISeeUTM supplements” he continues.

Moreover, joimax® also presented its latest product, the newly launched Intracs® Interaoperative Navigation Tracking & Control System for the first time in China.